Brain

Denali Therapeutics Announces First Participant Dosed in Phase 2a Study of LRRK2 Inhibitor, BIIB122, in LRRK2-Associated Parkinson’s Disease

SOUTH SAN FRANCISCO, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today announced initiation of dosing…

1 year ago

Annexon to Present Phase 2 ARCHER Data on Protection of Vision and Photoreceptors with ANX007 in Geographic Atrophy at the Floretina-ICOOR 2024 Meeting

Only Program that has Demonstrated Significant Vision Protection in Standard and Low Light Conditions and Significant Preservation of Photoreceptors in the…

1 year ago

Medicenna Provides Clinical Update and Announces First Complete Responder in MDNA11 and KEYTRUDA® (pembrolizumab) Combination Dose Escalation Arm of the ABILITY-1 Study

70-year-old patient with advanced chemo-refractory anal cancer achieves complete response (CR) in 8 weeks when treated with MDNA11 in combination…

1 year ago

BioGene Therapeutics Welcomes Ex Pfizer and Moderna Senior Leadership Dr. Barry Ticho

Vancouver, British Columbia--(Newsfile Corp. - December 5, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or…

1 year ago

EverythingALS and Compass UOL partner to advance artificial intelligence and computational biology by training and supporting 2,000 Top Talent to Cure ALS at AWS re:Invent 2024

AI Powers the Fight Against ALS LAS VEGAS, Dec. 4, 2024 /PRNewswire/ --A partnership between Compass UOL, an AI transformation…

1 year ago

A New VISION: Groundbreaking Collaboration Advances Whole Eye Transplants

Wake Forest Institute for Regenerative Medicine and BMI OrganBank are Key Partners in Stanford-Led Consortium to Advance Vision-Restoring Transplants WINSTON-SALEM,…

1 year ago

AGE-WELL announces new research projects to support healthy aging for Canadians

TORONTO, Dec. 4, 2024 /CNW/ - Following a competitive, nationwide call for proposals, AGE-WELL is pleased to announce funding for nine…

1 year ago

Lace AI Pro Expands Clinical Excellence with Acquisition of Amptify

GAINESVILLE, Fla., Dec. 4, 2024 /PRNewswire/ -- Neurotone AI, pioneer in aural rehabilitation, and creator of Lace AI Pro, today…

1 year ago

Lace AI Pro Expands Clinical Excellence with Acquisition of Amptify

GAINESVILLE, Fla., Dec. 4, 2024 /PRNewswire/ -- Neurotone AI, pioneer in aural rehabilitation, and creator of Lace AI Pro, today…

1 year ago

Boland Romaine LLP is Happy to Announce the Launch of it’s New Website to Better Serve Ontario’s Residents

Redefining Advocacy for the Injured and The Unsettling Truth About SettlingTORONTO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- In an effort…

1 year ago